Market Overview

UPDATE: Morgan Stanley Upgrades PerkinElmer to Overweight on Operating Margin Outlook

Related PKI
14 Healthcare Stocks Fundstrat Is Buying
Benzinga's Top Downgrades

Morgan Stanley raised its rating on PerkinElmer (NYSE: PKI) from Equal-weight to Overweight and established a $38 price target.

Morgan Stanley said, "While recent margin expansion has been impressive, there is more to go. The benefits of levering a mid-single digit top line plus more efficient integration of acquired businesses & several ongoing initiatives provide a pathway towards 20%+ EBIT margins, which we model by 2016, yielding EPS forecasts ~2-8% > consensus thru 2015. … Over the last 8 quarters, organic growth has averaged nearly 7% and management sees mid-single digit growth outlook as appropriate. We model a 5% CAGR through 2015, superior to most peers in our coverage universe."

PerkinElmer closed at $32.09 on Thursday.

Latest Ratings for PKI

Aug 2015Cantor FitzgeraldInitiates Coverage onBuy
Jul 2015CitigroupMaintainsBuy
Jun 2015Stifel NicolausMaintainsBuy

View More Analyst Ratings for PKI
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings


Related Articles (PKI)

View Comments and Join the Discussion!

Get Benzinga's Newsletters